Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Pasithea Therapeutics Corp. (KTTA) had Stock-Based Compensation of $0.10M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.56M |
|
-- |
|
-- |
|
$3.68M |
|
$-3.68M |
|
$0.12M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.56M |
|
$-3.68M |
|
$-3.52M |
|
2.21M |
|
2.21M |
|
$-1.61 |
|
$-1.61 |
|
| Balance Sheet Financials | |
$6.12M |
|
$0.12M |
|
$8.53M |
|
$14.66M |
|
$1.59M |
|
-- |
|
$0.09M |
|
$1.68M |
|
$12.98M |
|
$4.56M |
|
$12.98M |
|
2.71M |
|
| Cash Flow Statement Financials | |
$-3.06M |
|
-- |
|
$1.47M |
|
$6.92M |
|
$5.34M |
|
$-1.58M |
|
|
Stock-Based Compensation |
$0.10M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.84 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-27.45% |
|
-78.10% |
|
-24.31% |
|
-27.45% |
|
$4.80 |
|
$-1.38 |
|
$-1.38 |
|